BioCentury
ARTICLE | Clinical News

TRV027: Phase IIb data

May 23, 2016 7:00 AM UTC

Top-line data from the double-blind, international Phase IIb BLAST-AHF trial in 618 patients with AHF showed that IV TRV027 plus standard of care (SOC) missed the primary endpoint of improving a compo...